Another thing to note:
only 68% of patients in the PG treatment group were also on ARBs
vs.
80% of patients in the “usual care” group were on ARBs
doesn’t specify in the main text which ARBs these were either
- Forums
- ASX - By Stock
- DXB
- General Discussion
General Discussion, page-39
-
- There are more pages in this discussion • 96 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DXB (ASX) to my watchlist
|
|||||
Last
49.5¢ |
Change
0.020(4.21%) |
Mkt cap ! $261.3M |
Open | High | Low | Value | Volume |
47.5¢ | 50.0¢ | 47.5¢ | $412.8K | 847.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 131961 | 49.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
50.0¢ | 186780 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 131961 | 0.490 |
6 | 334600 | 0.485 |
10 | 174987 | 0.480 |
8 | 164155 | 0.475 |
7 | 173697 | 0.470 |
Price($) | Vol. | No. |
---|---|---|
0.500 | 186780 | 9 |
0.505 | 119000 | 2 |
0.510 | 240806 | 6 |
0.515 | 101650 | 2 |
0.520 | 107859 | 6 |
Last trade - 10.38am 16/07/2024 (20 minute delay) ? |
Featured News
DXB (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online